moclobemide has been researched along with Coronary Artery Disease in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilgrim, JL | 1 |
| Gerostamoulos, D | 1 |
| Woodford, N | 1 |
| Drummer, OH | 1 |
1 other study available for moclobemide and Coronary Artery Disease
| Article | Year |
|---|---|
Serotonin toxicity involving MDMA (ecstasy) and moclobemide.
Topics: Adult; Coronary Artery Disease; Forensic Toxicology; Hallucinogens; Humans; Liver; Lung; Male; Middl | 2012 |